What is PEPID?
PEPID is a distinguished provider of clinical decision support tools and comprehensive medical reference resources, catering to healthcare professionals, hospitals, and educational institutions. Established in 1994, PEPID has cultivated a robust platform designed to enhance critical decision-making processes by offering readily accessible and integrated drug information and medical content. Its solutions are relied upon by a diverse clientele, including emergency physicians, primary care practitioners, nurse practitioners, and medical students. PEPID's dedication to continuous improvement and the utilization of peer-reviewed content aims to elevate patient outcomes by equipping healthcare providers with essential knowledge precisely when and where it is needed.
How much funding has PEPID raised?
PEPID has raised a total of $656K across 2 funding rounds:
Debt
$350K
Debt
$306K
Debt (2020): $350K with participation from PPP
Debt (2021): $306K led by PPP
What's next for PEPID?
The recent major strategic investment signals a pivotal phase for PEPID, likely enabling the company to accelerate its product development, expand its market reach, and enhance its technological infrastructure. Given the enterprise-level nature of its total funding, PEPID is well-positioned to solidify its leadership in the clinical decision support market. Future strategies may involve deeper integration with electronic health record systems, further development of AI-driven diagnostic aids, and expansion into new geographical markets. This strategic capital infusion is expected to fuel innovation and reinforce PEPID's commitment to improving healthcare delivery through accessible, reliable medical information.
See full PEPID company page
